TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.080
-0.010 (-0.92%)
At close: Dec 5, 2025, 4:00 PM EST
1.090
+0.010 (0.94%)
After-hours: Dec 5, 2025, 7:55 PM EST
TScan Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -142.6 | -127.5 | -89.22 | -66.22 | -48.63 | -26.13 | |
| Depreciation & Amortization | 2.85 | 4.11 | 5.36 | 5.14 | 3.33 | 1.23 | |
| Loss (Gain) From Sale of Assets | - | - | - | - | - | 0 | |
| Loss (Gain) From Sale of Investments | -3.9 | -3.9 | -1.07 | - | - | - | |
| Stock-Based Compensation | 12.41 | 9.55 | 5.21 | 4.55 | 2.52 | 0.52 | |
| Other Operating Activities | 1.61 | 1.86 | 0.76 | 0.26 | - | - | |
| Change in Accounts Payable | 3.04 | 1.99 | -0.05 | 0.53 | 0.01 | 1.13 | |
| Change in Unearned Revenue | -8.42 | -2.82 | 11.89 | -9.03 | -6.54 | 19.44 | |
| Change in Other Net Operating Assets | 4.29 | 5.88 | 5.77 | -1.73 | 0.63 | 0.79 | |
| Operating Cash Flow | -130.73 | -110.82 | -61.36 | -66.5 | -48.68 | -3.02 | |
| Capital Expenditures | -5.12 | -3.83 | -3.15 | -4.23 | -9.94 | -4.24 | |
| Investment in Securities | 126.96 | -48.79 | -57.61 | - | - | - | |
| Investing Cash Flow | 121.84 | -52.61 | -60.76 | -4.23 | -9.94 | -4.24 | |
| Long-Term Debt Issued | - | 32.46 | - | 29.35 | - | - | |
| Long-Term Debt Repaid | - | -17.14 | - | - | - | - | |
| Net Debt Issued (Repaid) | 15.31 | 15.31 | - | 29.35 | - | - | |
| Issuance of Common Stock | 0.57 | 35.18 | 43.13 | 0.33 | 89.94 | 0.29 | |
| Other Financing Activities | 29.4 | 158.27 | 92.32 | -0.32 | - | - | |
| Financing Cash Flow | 45.28 | 208.77 | 135.44 | 29.36 | 189.67 | 0.29 | |
| Net Cash Flow | 36.39 | 45.33 | 13.33 | -41.37 | 131.05 | -6.97 | |
| Free Cash Flow | -135.85 | -114.65 | -64.5 | -70.73 | -58.62 | -7.26 | |
| Free Cash Flow Margin | -1612.88% | -4071.27% | -306.45% | -522.56% | -578.03% | -669.22% | |
| Free Cash Flow Per Share | -2.39 | -2.03 | -1.35 | -2.94 | -5.03 | -7.93 | |
| Cash Interest Paid | 2.34 | 2.88 | 3 | 0.66 | - | - | |
| Levered Free Cash Flow | -87.76 | -68.97 | -41.83 | -42.84 | -33.43 | -5.85 | |
| Unlevered Free Cash Flow | -85.98 | -66.69 | -39.48 | -42.1 | -33.43 | -5.85 | |
| Change in Working Capital | -1.1 | 5.05 | 17.61 | -10.23 | -5.9 | 21.36 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.